Last reviewed · How we verify

NCT07158658

Prospective Case Series Evaluating the Efficacy and Safety of NeoThelium FT for Chronic Pressure Ulcers

Recruiting now NA Last updated 13 April 2026
What this trial tests

NA trial testing NeoThelium FT (HCT/P 361) in Pressure Injury in 10 participants. Currently enrolling.

Timeline
1 December 2025
Primary endpoint
1 December 2026
1 January 2027

Quick facts

Lead sponsorNuScience Medical Biologics, LLC
PhaseNA
StatusRecruiting now
Study typeINTERVENTIONAL
Allocationna
Designsingle group
Maskingnone
Primary purposetreatment
Enrollment10
Start date1 December 2025
Primary completion1 December 2026
Estimated completion1 January 2027
Sites1 location across United States

Drugs / interventions tested

Conditions studied

Sponsor

NuScience Medical Biologics, LLC — full company profile →

Who can join

18 and older, any sex, with Pressure Injury. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This is a prospective case series evaluating the efficacy and safety of NeoThelium FT Amnion Skin Graft in the Mangement of Chronic Pressure Ulcers

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of NeoThelium FT (HCT/P 361)

Trials testing the same drug.

Other recruiting trials for Pressure Injury

Currently open trials in the same condition.

Other NuScience Medical Biologics, LLC trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07158658.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing